Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$8.68 - $27.49 $172,219 - $545,429
-19,841 Closed
0 $0
Q1 2021

Apr 27, 2021

BUY
$12.0 - $27.64 $4,572 - $10,530
381 Added 1.96%
19,841 $302,000
Q4 2020

Feb 03, 2021

BUY
$11.05 - $16.62 $20,431 - $30,730
1,849 Added 10.5%
19,460 $227,000
Q3 2020

Oct 27, 2020

BUY
$11.69 - $14.54 $205,872 - $256,063
17,611 New
17,611 $225,000

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $26.9M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Dynamic Advisor Solutions LLC Portfolio

Follow Dynamic Advisor Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Advisor Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Advisor Solutions LLC with notifications on news.